Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | N/A | 15,554 | 8,154 | 10,712 |
| Depreciation Amortization | 0 | N/A | 13,883 | 12,097 | 10,349 |
| Other Working Capital | 0 | N/A | -14,247 | -15,545 | -9,887 |
| Other Operating Activity | 48,274 | 22,527 | -11,225 | -570 | 911 |
| Operating Cash Flow | $48,274 | $22,527 | $3,965 | $4,136 | $12,085 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,798 | -14,549 | -20,426 | -30,950 | -13,413 |
| Net Acquisitions | 0 | N/A | N/A | N/A | -168 |
| Other Investing Activity | -3,258 | 5,785 | 8,357 | 4,327 | -3,998 |
| Investing Cash Flow | $-13,056 | $-8,764 | $-12,069 | $-26,623 | $-17,579 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -32,897 | -15,230 | 1,749 | 25,413 | 7,417 |
| Financing Cash Flow | $-32,897 | $-15,230 | $1,749 | $25,413 | $7,417 |
| Exchange Rate Effect | -1,682 | 1,893 | 4,210 | -105 | -2,822 |
| Beginning Cash Position | 3,112 | 2,686 | 4,831 | 2,010 | 2,909 |
| End Cash Position | 3,751 | 3,112 | 2,686 | 4,831 | 2,010 |
| Net Cash Flow | $639 | $426 | $-2,145 | $2,821 | $-899 |
| Free Cash Flow | |||||
| Operating Cash Flow | 48,274 | 22,527 | 3,965 | 4,136 | 12,085 |
| Free Cash Flow | 48,274 | 22,527 | 3,965 | 4,136 | 12,085 |